Regarding tumor metastasis, emerging evidence reveals that the CXCR7 agonist TC14012 exerts anti-metastatic effects by suppressing endothelial cell necroptosis, thereby inhibiting transendothelial migration of tumor cells and lung cancer metastasis. Here, ACKR3 is linked to lung cancer.